Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-31

Clinical Trial Update: Allopurinol and Quality of Life in Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating allopurinol for quality of life in patients with liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Tanta University | Conditions: Cirrhosis, Liver | Phase 2, Phase 3 | Status: COMPLETED